Passa al contenuto
Merck

LC/MS Analysis of Erythromycin Analogs on Ascentis® Express HILIC

LC/MS Analysis of Erythromycin Analogs on Ascentis® Express HILIC application for HPLC

Materiali

Colonna analitica

N° Catalogo
Descrizione
Determinazione del prezzo

53981-U

Ascentis® Express HILIC HPLC Column

2.7 μm particle size, L × I.D. 15 cm × 4.6 mm

Componente della fase mobile

N° Catalogo
Descrizione
Determinazione del prezzo

70221

Formato di ammonio

eluent additive for LC-MS, LiChropur™, ≥99.0%

Standard

N° Catalogo
Descrizione
Determinazione del prezzo

E8755

Erythromycin ethyl succinate

45674

Erythromycin

tested according to Ph. Eur.

1242021

Erythromycin C

United States Pharmacopeia (USP) Reference Standard

CONDITIONS

column

Ascentis Express HILlC, 15 cm x 4.6 mm I.D., 2.7 μm particles (53981-U)

mobile phase

[A] 100 mM ammonium formate, pH 3.0 (titrated with formic acid); [B] acetonitrile; (10:90, A:B)

flow rate

1.0 mL/min

pressure

1247 psi (86 bar)

column temp.

35 °C

detector

ESI(+); SIR

injection

5 μL

Descrizione

Risultati analitici

This application shows the suitability of Ascentis Express Silica columns for the analysis of erythromycin analogs in aqueous normal phase/HILIC mode of chromatography. Other relatively hydrophobic aminoglycosides have also been shown to separate under these conditions.

Note legali

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Chromatogram Search

Related Product Categories

HPLC ColumnsGC Columns & AccessoriesTLC Plates & AdsorbentsSolid Phase Microextraction (SPME)Solid Phase Extraction & QuEChERS

Related Applications

Small Molecule HPLCLarge Molecule HPLCGas Chromatography (GC)TLCSolid Phase Microextraction (SPME)Solid Phase Extraction (SPE)QuEChERS